Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor Jia GuNeng ZhuLi Qin Review 22 July 2022 Pages: 709 - 728
A comprehensive review of SHP2 and its role in cancer Moges Dessale AsmamawXiao-Jing ShiHong-Min Liu ReviewPaper 06 September 2022 Pages: 729 - 753
Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects Azam BozorgiMaryam BozorgiMozafar Khazaei Review 09 August 2022 Pages: 755 - 777
HDAC6: A unique HDAC family member as a cancer target Sumeet KaurPrerna RajoriaMadhu Chopra Review 29 August 2022 Pages: 779 - 829
Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer Alejandro Schcolnik-CabreraDaniel Juárez-López Review 29 August 2022 Pages: 831 - 859
Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway Yunfeng SongLei YeYiran Li Original Article 11 August 2022 Pages: 861 - 872
Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer Pranay DeyMansi JoshiAbhijit De Original Article 14 July 2022 Pages: 873 - 891
YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma Yi-Zih KuoYa-Rong KangLi-Wha Wu Original Article Open access 05 August 2022 Pages: 893 - 909
Correction to: YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma Yi-Zih KuoYa-Rong KangLi-Wha Wu Correction Open access 12 October 2022 Pages: 911 - 911
Activation of the HSP27-AKT axis contributes to gefitinib resistance in non-small cell lung cancer cells independent of EGFR mutations Seul-Ki ChoiMinsuh KimYun-Sil Lee Original Article Open access 05 August 2022 Pages: 913 - 930
A m6A methyltransferase-mediated immune signature determines prognosis, immune landscape and immunotherapy efficacy in patients with lung adenocarcinoma Mengyuan LeiChenghan LuoMin Zhao Original Article 15 August 2022 Pages: 931 - 949
Proteasomal deubiquitylase activity enhances cell surface recycling of the epidermal growth factor receptor in non-small cell lung cancer Shanshan WangTaishu WangShuyan Liu Original Article 21 September 2022 Pages: 951 - 965
Nm23-H1 induces apoptosis in primary effusion lymphoma cells via inhibition of NF-κB signaling through interaction with oncogenic latent protein vFLIP K13 of Kaposi’s sarcoma-associated herpes virus Suchitra MohantyAmit KumarTathagata Choudhuri Original Article 14 August 2022 Pages: 967 - 989
Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models Janina Fischer-MertensFelix OtteMatthias Fischer Original Article Open access 12 August 2022 Pages: 991 - 1003
Combination of RSK inhibitor LJH-685 and FLT3 inhibitor FF-10101 promoted apoptosis and proliferation inhibition of AML cell lines Sen ZhangJun LiuQing-Yun Wu Original Article 29 August 2022 Pages: 1005 - 1018
Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer Linfeng XianPei ZhaoGuangwen Cao Original Article 29 August 2022 Pages: 1019 - 1036
Correction to: CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer Zhenyu ZhouYaorong PengWenbin Li Correction 01 September 2022 Pages: 1037 - 1041